MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 4.850
-0.180 (-3.58%)
Jul 17, 2026, 1:58 PM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 2.57 billion as of July 17, 2026. Its market cap has increased by 12.52% in one year.
Market Cap
2.57B
Enterprise Value
2.85B
Revenue
635.85M
Ranking
n/a
PE Ratio
61.63
Stock Price
4.85
ChartMarket Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 2.57B, a decrease of -41.29%. That is a compound annual growth rate of -19.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 2.57B | 5.52% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
| Feb 5, 2024 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 519.42B |
| Caliway Biopharmaceuticals | 176.65B |
| Heron Neutron Medical | 68.90B |
| Pell Bio-Med Technology | 66.74B |
| GlycoNex Incorporation | 2.69B |
| ShareHope Medicine | 2.68B |
| Qing Song Health | 2.62B |
| Applied BioCode | 2.59B |